An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry

Radiotherapy and Oncology

Volumn 91, Issue 2, 2009, Pages 243-248

  Toye, Warren ^a,b   Das, Ram ^c   Kron, Tomas ^b,c   Franich, Rick ^b   Johnston, Peter ^b   Duchesne, Gillian ^c,d  

^a Radiation Oncology Victoria   (Australia)

^b RMIT UNIVERSITY   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Brachytherapy; Corrective action; Dosimetry; HDR; In vivo; Investigative protocol; Prostate; Rectal dosimetry; TLD; Urethral dosimetry

Indexed keywords

ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RECTUM; THERMOLUMINESCENCE DOSIMETRY; URETHRA;

BRACHYTHERAPY; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RECTUM; THERMOLUMINESCENT DOSIMETRY; URETHRA;

EID: 65449117526     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.08.016     Document Type: Article

References (13)

1. Damore S.J., Syed N., Puthawala A.A., and Sharma A. Needle displacement during HDR brachytherapy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 56 (2000) 1205-1211
2. Hoskin P.J., Bownes P.J., Ostler P., et al. High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. Radiother Oncol 68 (2003) 285-288
3. Mullokandov E., and Gejerman G. Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy. Int J Radiat Oncol Biol Phys 58 (2004) 1063-1071
4. Das R., Toye W., Kron T., Williams S., and Duchesne G. Thermoluminescence dosimetry for in vivo verification of high dose rate brachytherapy for prostate cancer. Australas Phys Eng Sci Med 30 (2007) 178-184
5. Brezovich I.A., Duan J., Pareek P.N., et al. In vivo urethral dose measurements: a method to verify high dose rate prostate treatments. Med Phys 27 (2000) 2297-2301
6. Anagnostopoulos G., Baltas D., Geretschlaeger A., et al. In vivo thermoluminescence dosimetry dose verification of transperineal 192Ir high-dose-rate brachytherapy using CT-based planning for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 57 (2003) 1183-1191
7. Duchesne G.M., Das R., Toye W.C., and See A. Dose distribution and morbidity after high dose rate brachytherapy for prostate cancer: influence of V150 and V200 parameters. Australas Radiol 46 (2002) 384-389
8. Martinez A., Gonzalez J., and Stromberg J. Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalation trial. Int J Radiat Oncol Biol Phys 33 (1995) 1019-1027
9. 192 Ir prostate brachytherapy: feasibility report. Int J Radiat Oncol Biol Phys 41 (1998) 525-533
10. Kawakow I, Rogers DWO. The EGSnrc code system: Monte Carlo simulation of electron and photon transport: NRCC Report PIRS-701 (National Research Council of Canada, Ottawa); 2003.
11. Rogers DWO, Kawakow I, Seuntens JP, Walters BRB. NRC user codes for EGSnrc NRCC Report PIRS-702(revB) (National Research Council of Canada, Ottawa); 2005.
12. Vargas C.E., Martinez A.A., Boike T.P., et al. A high-dose-rate brachytherapy boost: results of a phase I and II study. Int J Radiat Oncol Biol Phys 66 (2005) 415-423
13. Cygler J.E., Saoudi A., Perry G., and Morash C. Feasibility study of using MOSFET detectors for in vivo dosimetry during permanent low-dose-rate prostate implants. Radiother Oncol 80 (2006) 296-301